paraganglioma
Showing 1 - 25 of 33
Fluorescence Guided Minimally-Invasive Resection Of Abdominal
Recruiting
- Paraganglioma
- Fluorescence guided identification using indocyanine green
-
Leiden, NetherlandsLeiden University Medical Center
Dec 1, 2023
F-18 FDOPA PET/CT Versus I-123 MIBG Scintigraphy With SPECT/CT
Terminated
- Pheochromocytoma
- Paraganglioma
- F-18 FDOPA PET/CT
-
Seoul, Songpa-gu, Korea, Republic ofAsan Medical Center
Jul 13, 2023
Pheochromocytoma, Paraganglioma Trial in Beijing (Temozolomide)
Recruiting
- Pheochromocytoma
- Paraganglioma
-
Beijing, ChinaPeking Union Medical College Hospital
May 22, 2023
Pheochromocytoma, Paraganglioma Trial in Beijing (Anlotinib HCl)
Recruiting
- Pheochromocytoma
- Paraganglioma
- Anlotinib hydrochloride
-
Beijing, ChinaPeking Union Medical College Hospital
May 22, 2023
Pheochromocytoma, Paraganglioma, Adrenalectomy; Status Trial in Seoul (Phenoxybenzamine)
Recruiting
- Pheochromocytoma
- +3 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jan 18, 2023
Pheochromocytoma, Paraganglioma, Neuroendocrine Tumors Trial run by the NCI (Lu-177-DOTATATE, Ga-68-DOTATATE, F-18-FDG)
Recruiting
- Pheochromocytoma
- +3 more
- Lu-177-DOTATATE
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial run by the National Cancer
Recruiting
- Adrenal Gland Pheochromocytoma
- +3 more
- Computed Tomography
- +2 more
-
Bethesda, Maryland
- +1 more
Jan 3, 2023
Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester
Not yet recruiting
- Neuroendocrine Tumors
- +8 more
-
Iowa City, Iowa
- +1 more
Nov 23, 2022
Pheochromocytoma, Paraganglioma Trial in Philadelphia ([18F]FluorThanatrace ([18F]FTT))
Not yet recruiting
- Pheochromocytoma
- Paraganglioma
- [18F]FluorThanatrace ([18F]FTT)
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Dec 1, 2022
Pheochromocytoma, Paraganglioma Trial in Marseille (Infrared themrography)
Recruiting
- Pheochromocytoma
- Paraganglioma
- Infrared themrography
-
Marseille, Paca, FrancePôle ENDO- Hopital la Conception APHM
Nov 12, 2022
DOTATOC PET/CT for Imaging NET Patients
Recruiting
- Neuroendocrine Tumors
- +15 more
- 68Ga-DOTATOC PET/CT
- 18F-FDG PET/CT
-
Vancouver, British Columbia, CanadaBC Cancer
Nov 2, 2022
Pheochromocytoma, Paraganglioma Trial in New York (Axitinib)
Recruiting
- Pheochromocytoma
- Paraganglioma
-
New York, New YorkColumbia University Irving Medical Center
Oct 5, 2022
68-Ga DOTATATE PET/MRI in Diagnosis and Management of
Recruiting
- CNS Tumors
- +6 more
- Ga68-DOTATATE-PET/MRI
-
New York, New YorkWeill Cornell Medicine
Sep 20, 2022
Pheochromocytoma, Paraganglioma, Inherited Cancer Syndrome Trial in San Antonio (Genetic screening)
Recruiting
- Pheochromocytoma
- +7 more
- Genetic screening
-
San Antonio, TexasUniversity of Texas Health Science Center
Aug 25, 2022
Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen
Recruiting
- Acinar Cell Carcinoma
- +93 more
- Biospecimen Collection
- +2 more
-
Birmingham, Alabama
- +998 more
Aug 23, 2022
Dysglycemia in Pheochromocytoma and Paraganglioma
Active, not recruiting
- Pheochromocytoma
- Paraganglioma
- Catecholamines
-
Beijing, Beijing, ChinaXian-Liang Zhou
Jul 9, 2022
Exendin PET/CT for Imaging of Paragangliomas
Recruiting
- Paraganglioma
- 68Ga-NODAGA-exendin-4 PET/CT
-
Nijmegen, NetherlandsRadboud University Medical Center
Jun 13, 2022
Gastroenteropancreatic Neuroendocrine Tumors, Pheochromocytoma, Paraganglioma Trial in Worldwide (Lutetium [177Lu]
Recruiting
- Gastroenteropancreatic Neuroendocrine Tumors
- +2 more
- Lutetium [177Lu] oxodotreotide/dotatate
-
Iowa City, Iowa
- +16 more
Apr 6, 2022
Neuroendocrine Tumor, Anaplastic Thyroid Cancer, Adenocarcinoma Trial in Spain (Cabozantinib 40 mg)
Recruiting
- Neuroendocrine Tumor
- +4 more
- Cabozantinib 40 mg
-
Badalona, Barcelona, Spain
- +14 more
Feb 15, 2022
Pheochromocytoma, Paraganglioma, Cardiovascular Morbidity Trial in Lucknow (Observational study)
Completed
- Pheochromocytoma
- +2 more
- Observational study
-
Lucknow, Uttar Pradesh, IndiaSanjay Gandhi Postgraduate Institute of Medical Sciences
Feb 9, 2022
Prognostic's Factors of Head and Neck Paragangliomas Evolution
Not yet recruiting
- Paraganglioma
- Characterization of a population with cervical paragangliomas
-
Bron, FranceFédération d'endocrinologie Hôpital Cardiologique/Groupement Hos
Jan 31, 2022
Development ofTele-monitoring Program for Patients Undergoing
Recruiting
- Pheochromocytoma
- Paraganglioma
- Use of an internet plateform
-
Paris, FranceHopital européen Georges Pompidou
Jan 17, 2022
Adrenocortical Carcinoma, Pheochromocytoma, Paraganglioma Trial in Worldwide (EO2401)
Recruiting
- Adrenocortical Carcinoma
- +2 more
- EO2401
-
Houston, Texas
- +9 more
Dec 7, 2021